ARTICLE | Management Tracks
Murphy leaving Kinnate as CSO
Adib replaces Chlosta at Triumvira, plus Integra, Inscopix, CinCor, PepGen and Temedica
October 28, 2021 10:48 PM UTC
Eric Murphy will depart Kinnate Biopharma Inc. (NASDAQ:KNTE) as CSO on Dec. 3 to pursue a new opportunity. He will join the oncology company’s SAB.
T cell therapy company Triumvira Immunologics Inc. hired Deyaa Adib to succeed Sabine Chlosta as CMO. Adib was CMO at Rain Therapeutics Inc. (NASDAQ:RAIN) and VP of late-stage development at Blueprint Medicines Corp. (NASDAQ:BPMC). He also held leadership roles in oncology clinical development at Aventis, Sanofi (Euronext:SAN; NASDAQ:SNY) and Astellas Pharma Inc. (Tokyo:4503)...